Technology Readiness Level (TRL) scale is an industrially applied concept that outlines different R&D steps, which support the innovation and industrialization process of technologies to transform ideas to the market. Check the TRL scale below to understand what NextGenRnD has on offer.
|Tech qualified through successful operations – Proof of Performance||9||Technology has proven successful in its mission operations (full commercial application)|
|Tech completed through test and demo||8||Technology completed and qualified through test and demonstration (first of the kind commercial system)|
|Prototype demo in operational environment||7||Integration and demonstration of industrial prototype system in the operational environment (demonstration system)|
|Prototype demo in relevant environment – Proof of Principle||6||Prototype system scale-up and demonstration of commercial-scale system in the intended environment|
|Tech validation in relevant environment||5||Testing and validation of discrete technology components' combination in the intended environment – synergy of technology components (prototype)|
|Tech validation in lab environment||4||Identification and validation of discrete technology components in the laboratory environment|
|Analytical & experimental Proof of Concept||3||
Critical function of technology/application demonstrated through experimentation
|Tech concept/application formulated||2||
Technology concept/application development
|Basic principles observed||1||
Basic principles observed or postulated, no experimental proof or detailed analysis yet exists
|Rapid internalizing antibody identification platform||$1500||
|Gene therapy targeting platform||$1500||
|Galvanized virus – determine the lipid composition of every virion in a virus sample population||$2500||
|Systemic therapeutic peptide delivery via gastrointestinal tract||$2500||
|Protection of thermally sensitive proteins added to poultry and swine feed||$3000||
|Lawsonia intracellularis propagation – a large-scale intracellular pathogen cultivation model||$3500||
|Novel drug targets for tuberculosis therapy||$4000||
|Muscle targeting platform||$4500||
|Longitudinal detection and quantification of intrathecally-injected antisense oligonucleotides in brain using intravenously delivered probe||$5000||
|Novel quantitative, robust and high-throughput assay for monitoring tau protein aggregation||$6000||
|Airway smooth muscle spheroid contraction sensor platform||$10000||
|Novel formulation for mRNA vaccines delivery||$10000||
The solution is very effective under laboratory conditions.
We were impressed by the description of the in vitro model and the level of detail provided, including the research plan as well as the underlying expertise.
The solution was detailed in the process, modeling and principles of attenuation.
The solution is very complete and innovative.
The solution was extremely detailed and well planned.